[1]
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7:135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25
[PubMed PMID: 28122885]
[3]
Barton M, Grüntzig J, Husmann M, Rösch J. Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985). Frontiers in cardiovascular medicine. 2014:1():15. doi: 10.3389/fcvm.2014.00015. Epub 2014 Dec 29
[PubMed PMID: 26664865]
[4]
Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet (London, England). 1978 Feb 4:1(8058):263
[PubMed PMID: 74678]
[5]
Berkefeld J, Wagner M, du Mesnil R. Carotid Stenting in Neuroradiology : A Short Journey from the Past to Current Debates. Clinical neuroradiology. 2017 Dec:27(4):409-415. doi: 10.1007/s00062-017-0603-y. Epub 2017 Jun 16
[PubMed PMID: 28623378]
[6]
Lindquist J, Schramm K. Drug-Eluting Balloons and Drug-Eluting Stents in the Treatment of Peripheral Vascular Disease. Seminars in interventional radiology. 2018 Dec:35(5):443-452. doi: 10.1055/s-0038-1676360. Epub 2019 Feb 5
[PubMed PMID: 30728660]
[7]
Jaff MR, Nelson T, Ferko N, Martinson M, Anderson LH, Hollmann S. Endovascular Interventions for Femoropopliteal Peripheral Artery Disease: A Network Meta-Analysis of Current Technologies. Journal of vascular and interventional radiology : JVIR. 2017 Dec:28(12):1617-1627.e1. doi: 10.1016/j.jvir.2017.08.003. Epub 2017 Oct 12
[PubMed PMID: 29031986]
Level 1 (high-level) evidence
[9]
Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V, FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. The New England journal of medicine. 2012 Dec 20:367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4
[PubMed PMID: 23121323]
[10]
Giustino G, Serruys PW, Sabik JF 3rd, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Ragosta M 3rd, Kron IL, Liu Y, Zhang Z, McAndrew T, Dressler O, Généreux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial. JACC. Cardiovascular interventions. 2020 Feb 10:13(3):375-387. doi: 10.1016/j.jcin.2019.09.019. Epub 2020 Jan 15
[PubMed PMID: 31954680]
[11]
Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM 3rd, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Pagé P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Généreux P, Crowley A, Dressler O, Serruys PW, EXCEL Trial Investigators. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. The New England journal of medicine. 2019 Nov 7:381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28
[PubMed PMID: 31562798]
[12]
. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995 May 10:273(18):1421-8
[PubMed PMID: 7723155]
[13]
Zhu Z, Yu W. Update in the treatment of extracranial atherosclerotic disease for stroke prevention. Stroke and vascular neurology. 2020:5(1):65-70. doi: 10.1136/svn-2019-000261. Epub 2019 Nov 7
[PubMed PMID: 32411410]
[14]
Bonati LH, Lyrer P, Ederle J, Featherstone R, Brown MM. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. The Cochrane database of systematic reviews. 2012 Sep 12:(9):CD000515. doi: 10.1002/14651858.CD000515.pub4. Epub 2012 Sep 12
[PubMed PMID: 22972047]
Level 1 (high-level) evidence
[15]
Conte MS, Pomposelli FB. Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. Journal of vascular surgery. 2015 Mar:61(3 Suppl):1S. doi: 10.1016/j.jvs.2014.12.006. Epub 2015 Feb 23
[PubMed PMID: 25721065]
Level 1 (high-level) evidence
[16]
Dayama A, Panneton JM. Commentary: Appropriateness of Endovascular Therapy in Chronic Limb-Threatening Ischemia Patients Based on the Global Vascular Guidelines. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2020 Aug:27(4):614-615. doi: 10.1177/1526602820928589. Epub 2020 Jun 4
[PubMed PMID: 32495685]
[17]
PLOS ONE Staff. Correction: Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials. PloS one. 2020:15(5):e0233923. doi: 10.1371/journal.pone.0233923. Epub 2020 May 22
[PubMed PMID: 32442223]
Level 1 (high-level) evidence
[18]
Cole TS, Mezher AW, Catapano JS, Godzik J, Baranoski JF, Nakaji P, Albuquerque FC, Lawton MT, Little AS, Ducruet AF. Nationwide Trends in Carotid Endarterectomy and Carotid Artery Stenting in the Post-CREST Era. Stroke. 2020 Feb:51(2):579-587. doi: 10.1161/STROKEAHA.119.027388. Epub 2019 Dec 18
[PubMed PMID: 31847750]
[19]
Rychlik J, Hornacek I, Tejc M, Petrikovits E, Klimsa Z. Retrospective analysis of coronary interventions in a single centre and comparison of specific differences between radial and femoral access. Acta cardiologica. 2019 Aug:74(4):325-330. doi: 10.1080/00015385.2018.1494115. Epub 2018 Sep 7
[PubMed PMID: 30193077]
Level 2 (mid-level) evidence
[20]
Tomassini F, Tarantino F, Cerrato E, Quadri G, Rolfo C, Varbella F. Choice of vascular access in primary PCI. Minerva cardioangiologica. 2018 Aug:66(4):400-410. doi: 10.23736/S0026-4725.18.04629-7. Epub 2018 Feb 1
[PubMed PMID: 29393606]
[21]
Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, Summaria F, Patrizi R, Borghi A, Di Russo C, Moretti C, Agostoni P, Loschiavo P, Lioy E, Sheiban I, Sangiorgi G. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. Journal of the American College of Cardiology. 2012 Dec 18:60(24):2481-9. doi: 10.1016/j.jacc.2012.06.017. Epub 2012 Aug 1
[PubMed PMID: 22858390]
Level 1 (high-level) evidence
[22]
Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. The American journal of cardiology. 1992 Jan 1:69(1):63-8
[PubMed PMID: 1729869]
[23]
Carrozza JP Jr, Baim DS. Complications of directional coronary atherectomy: incidence, causes, and management. The American journal of cardiology. 1993 Oct 18:72(13):47E-54E
[PubMed PMID: 8213570]
[24]
Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Watanabe H, Yamaji K, Watanabe H, Kato T, Saito N, Ando K, Kadota K, Furukawa Y, Kimura T, CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria. Circulation journal : official journal of the Japanese Circulation Society. 2020 Apr 24:84(5):723-732. doi: 10.1253/circj.CJ-19-1117. Epub 2020 Mar 17
[PubMed PMID: 32188831]
[25]
Argulian E, Patel AD, Abramson JL, Kulkarni A, Champney K, Palmer S, Weintraub W, Wenger NK, Vaccarino V. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. The American journal of cardiology. 2006 Jul 1:98(1):48-53
[PubMed PMID: 16784919]
[26]
Slater J, Selzer F, Dorbala S, Tormey D, Vlachos HA, Wilensky RL, Jacobs AK, Laskey WK, Douglas JS Jr, Williams DO, Kelsey SF. Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry). The American journal of cardiology. 2003 Oct 1:92(7):773-8
[PubMed PMID: 14516874]
[27]
Kennedy JW. Complications associated with cardiac catheterization and angiography. Catheterization and cardiovascular diagnosis. 1982:8(1):5-11
[PubMed PMID: 7060118]
[28]
Cannan CR, Yeh W, Kelsey SF, Cohen HA, Detre K, Williams DO. Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. The American journal of cardiology. 1999 Jul 15:84(2):170-5
[PubMed PMID: 10426335]
[29]
Chambers CE, Eisenhauer MD, McNicol LB, Block PC, Phillips WJ, Dehmer GJ, Heupler FA, Blankenship JC, Members of the Catheterization Lab Performance Standards Committee for the Socitey for Cardiovascular Angiography and Interventions. Infection control guidelines for the cardiac catheterization laboratory: society guidelines revisited. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2006 Jan:67(1):78-86
[PubMed PMID: 16331649]
[30]
Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. Journal of the American College of Cardiology. 2006 Jan 3:47(1):175-81
[PubMed PMID: 16386683]
Level 3 (low-level) evidence